City-based pharmaceutical company, Lee Pharma on Friday said it has received Marketing Authorisation to market Bio-Cartilage Smoothwalk Tablets in United Arab Emirates region.
This tablet is the first product in the nutraceutical segment from India to get approved in UAE.
Bio-Cartilage Smoothwalk Tablets contain collagen type II, natural egg shell membrane, Boswellia and curcumin with vitamin D3 which mainly acts on joint and connective tissue disorders to increase cartilage in joints. The tablet is a Novel Composition of Bio Nutraceuticals with potent Phyto Nutrients to prevent joint and connective tissue disorders.
“Bio-Cartilage Smoothwalk Tablets are already well accepted in India. It is being used in prevention therapy of knee surgery. The tablet gives relief for the patients who are suffering with painful and progressive arthritis,” Director of Lee Pharma, Alla Leela Rani said.
The Director further informed that the product is under registration in all Middle East, East Asian Countries.
The Company is scheduled to file the Dossier for marketing authorization in the US in the third quarter of 2024.
“We have observed that a dosage of two to three tablets of Bio-Cartilage Smoothwalk Tablets administered to arthritis patients in a day is getting them relief from the pain within three weeks. This improves lubrication, mobility and flexibility in joints which may also help to avoid surgeries,” Alla Leela Rani added.
